SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-079672
Filing Date
2024-07-01
Accepted
2024-07-01 16:30:36
Documents
11
Period of Report
2024-06-25
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K apvo-20240625.htm   iXBRL 8-K 40530
  Complete submission text file 0000950170-24-079672.txt   158334

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT apvo-20240625.xsd EX-101.SCH 26036
13 EXTRACTED XBRL INSTANCE DOCUMENT apvo-20240625_htm.xml XML 4925
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37746 | Film No.: 241091074
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)